StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.00−0.08 (-0.88%)

Close on Nov 18, 2026Market cap $40.97MP/E –Yield –

Harvard Bioscience market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Harvard Bioscience's market cap was $44.07M on Nov 11, 2026, against $33.93M a year earlier. Over the last 5 years it ranged from $15.70M to $287.70M, with a median of $117.31M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$44.07M+47.8%
2025Dec 31, 2025$29.81M-67.6%
2024Dec 31, 2024$92.03M-59.7%
2023Dec 29, 2023$228.38M+97.9%
2022Dec 30, 2022$115.39M-59.9%
2021Dec 31, 2021$287.70M+72.1%
2020Dec 31, 2020$167.20M+44.0%
2019Dec 31, 2019$116.10M-2.1%
2018Dec 31, 2018$118.57M+3.0%
2017Dec 29, 2017$115.11M+9.8%
2016Dec 30, 2016$104.84M-11.0%
2015Dec 31, 2015$117.79M-35.8%
2014Dec 31, 2014$183.58M+26.9%
2013Dec 31, 2013$144.69M+14.7%
2012Dec 31, 2012$126.11M+14.5%
2011Dec 30, 2011$110.19M-9.8%
2010Dec 31, 2010$122.18M–

More Harvard Bioscience figures

See a number that looks wrong?